MT- secretory Flashcards
(100 cards)
Why need membrane trafficking? (3)
- Compartmentalisation: targeting of proteins to specific locations.
- Retrieve proteins back to resident compartment e.g. a receptor to be internalised with antigen etc and need to go back to membrane.
- secretory pathway.
- Endocytic pathway. - for signalling or degradation.
What is constitutive secretion?
Constitutive secretion: Secretion without any signals needed.
What is regulated secretion?
Regulated secretion: Needs sorting signals to say where to go and signals for release.
ER proteins have a ….?
KDEL sequence.
Signal sequence targets proteins to the ER.
e.g. V SNARES etc so can recycle back to the ER.
Organelles ER secretion?
ER- ER Golgi Intermediate compartment (ERGIC or VTC)-Cis Golgi Network- Cis Golgi- Medial Golgi- Trans Golgi- Trans Golgi Network (TGN)- Secretory vesicle to PM.
Organelle order of endocytic pathway?
PM- Endocytic Vesicle-Early endosome- Late Endosome/MVB- intraluminal vesicles- Lysosome for degradation.
Glycosylations are? To where?
addition of a sugar residue to a protein. Either N (Asparagine) and O(found on serine and theonine) linked glycosylations in the ER or Golgi.
What is a common residue sequence sugars can be added to?
In the ER lumen, when theres an asparagine, something, then a serine/theonine (N-x-S/T) motif, a preformed sugar can be added by an oligosaccharidal transferase.
Enzymes that can trim down glycosylations?
Glycosylase.
Experimental evidence for glycosylation?
CFTR glycosylation- band C complex glycosylated in Golgi, or band B core glycosylated in ER.
Know? Delta F508 paper, if force the unconventional pathway (e.g. mutant Sar1, upregulate syntaxin 5 sequests SNARES) which skips the Golgi this can still get to surface but not complex glycosylated, only core. Can see this on western blots as band B has a lower MW.
Purpose of glycosylation?
- Asist and stabilises the folding of the protein.
- Form a site for adhesion to another protein or extracellular matrix. dystroglycan
- Interaction site for ligand. e.g Staphylococcus aureus toxin/
- Can affect trafficking to places on membrane.
- Give protein complexity, depending on enzymes present and levels can give different sugars- gives different properties on different cells etc. e.g. blood type.
Example of glycosylation giving specificity to a protein?
Blood types.
Different O-linked sugars.
Example of glycosylation affecting Interaction site?
Staphylococcus aureus toxin binds to specific sialic acid residue additions(monosaccaride often found at terminal end of oligosaccharides giving protein a negative charge) on certain human cell surface glycosylated proteins. Uses this to get its toxins into cells.
Example of glycosylation giving stability to a protein and interactions with other proteins?
Certain muscular dystrophies are caused by the absence of certain sugars on the protein dystroglycan. It isn’t a defect in a protein but in the sugar addition which normally makes muscles more robust.
Dystroglycan links dystrophin to the extracellular matrix around muscle cells. Its sugars are important for facilitating this interaction. Without dystroglycan people will get muscular dystrophy, but loss of sugars can cause different type.
What might make a model suitable for studies on membrane trafficking?
Simplicity - trafficking occurs on a cellular scale so a single celled organism is likely to provide information.
Analysis of specific types of secretion e.g regulated secretion, would need a model system that is able to perform this function.
Often different systems reveal different information
Positives and negatives of yeast model organisms for membrane trafficking?
Positives:cheap, no ethic problems, genetic studies easy(can grow haploid or diploid), genome sequenced, many conserved paths.
Negative: Limited gene diversity, limited cell-cell contact so unlikely to be informative about multicellularity, small (5µm), so high resolution imaging studies of intracellular compartments is difficult. Has a cell wall which can preclude some types of studies- e.g. microinjection studies.
Study that investigated the secretory pathway in yeast?
Novick and Schekman 1980.
What was the rationale behind the Novick and Schekamn 1980 experiment?
mutate certain genes and if vesicles couldn’t be secreted i.e cells were secretory deficient (sec-), the cell would increase its density as these vesicles accumulate. These cells would also accumulate proteins that are normally secreted (invertase, acid phosphatase).
Novick and Schekamn 1980 experimental procedure to separate sec mutants?
- yeast cells were mutagenized randomly and shifted to a restrictive growth temperature (37°C) and then fractionated in a gradient forming medium.
- A 5% increase in density of the sec mutants gave complete separation from a population of wild type cells.
- The densest 1-2% of cells were tested further (separated by centrifugation.) These were the mutated, and an increase in density was due to an accumulation of cargo that couldnt be secreted.
What did Novick and Schekamn 1980 then do with the sec mutants identified?
- The densest 1-2% of cells were put under electron microscopy to see alterations in the normal ultra-structure of cells e.g accumulation of vesicles or Berkeley body formations inside cell.
- Certain proteins can be detected which are modified at different stages through the secretory pathway (e.g glycosylated or proteolytically cleaved) to see where the mutation was.
- Novick and Schekman analysed cells for their ability to secrete invertase and acid phosphatase at permissive and restrictive temperatures.
How did Novick and Schekman 1980 define secretory mutants?
They defined secretory mutants as those strains which fail to export active invertase and acid phosphatase, but continued to synthesize protein under restrictive growth conditions.(so not synthesis problems) These assays looked for defects in secretion but not establishing the stage of the defect. Invertase- mutants plates did not go brown as they did not secrete this.
How is the ultrastructure of Sec mutants different?
Vesicles budding off golgi or ER are seen in the cytoplasm unable to be secreted. Also formation of Berkleley bodies, double membraned strucures. Discovered in 1980 by Novick and Schekman, of the University of California, Berkeley.
Example of well studied protein that’s modified before being secreted? How is it modified?
Alpha-factor. Made as a Pre-Pro form. Oligosaccharides added, then modified, e.g. mannose added. In late golgi, KEX 2 chops it up into 4 mature alpha-factor proteins. Oligosaccharides function to ensure the protease recognises the protein and folds correctly.
Results of Novick and Schekman experiment?
23 sec genes were identified (genes required for secretion from ER to PM) in Yeast. These could be put into 5 categories Class A-E depending on the stage of the block in secretion.
A- accumulation in cytosol. B- RER, C-ER to Golgi vesicles, D-Golgi, E-secretory vesicles.